Krishna Institute of Medical Sciences Limited (IN:KIMS)
:KIMS
Want to see IN:KIMS full AI Analyst Report?
KIMS Stock Chart & Stats
₹653.00
₹11.55(1.78%)
At close: 4:00 PM EST
₹653.00
₹11.55(1.78%)
Day’s Range― - ―
52-Week Range₹575.55 - ₹798.00
Previous CloseN/A
Volume1.26M
Average Volume (3M)23.04K
Market Cap
₹260.93B
Enterprise Value₹296.06B
Total Cash (Recent Filing)₹1.74B
Total Debt (Recent Filing)₹31.87B
Price to Earnings (P/E)114.0
Beta0.78
Next Earnings
May 14, 2026EPS Estimate
1.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.30
Shares Outstanding400,138,950
10 Day Avg. Volume26,167
30 Day Avg. Volume23,042
Financial Highlights & Ratios
PEG Ratio2.68
Price to Book (P/B)11.57
Price to Sales (P/S)8.24
P/FCF Ratio-57.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹792.50Price Target Upside21.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)13.34
Revenue Forecast (FY)₹49.64B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained top-line expansion more than doubled revenue over three years, indicating durable demand for tertiary/quaternary hospital services and effective network scale. This growth provides a structural foundation for continued capacity investments, specialty mix improvement, and long-term market share gains.
Stable MarginsConsistent gross margins and a rising net margin reflect sustained cost control and operating leverage across clinical services. Stable high gross margins in a hospital network point to pricing power in specialty procedures and resilience against input cost swings, supporting durable profitability.
Operating Cash GenerationStrong and improving operating cash flow with OCF well above reported net income signals high earnings quality and cash conversion from core hospital operations. Robust OCF underpins capacity to service debt, fund working capital, and sustain reinvestment even if free cash flow is temporarily negative.
Bears Say
Rising LeverageLeverage increase to a 1.20 debt/equity level raises structural financial risk for a capital-intensive hospital operator. Higher debt magnifies interest burden and refinancing exposure, reducing flexibility for further network expansion or cushioning during demand softness over the coming months.
Negative Free Cash FlowPersistent negative free cash flow from heavy capex constrains liquidity and forces reliance on external financing or higher leverage to fund growth. Over a 2-6 month horizon this reduces capacity for discretionary investment, dividends, or rapid deleveraging and increases funding risk.
EPS ContractionNegative EPS growth despite rising revenues suggests dilution from financing costs, higher depreciation or margin volatility. This structural divergence between revenue and per-share earnings can weigh on shareholder returns and signals the company must manage costs, capital structure, or share count to restore EPS momentum.
Krishna Institute of Medical Sciences Limited News
KIMS FAQ
What was Krishna Institute of Medical Sciences Limited’s price range in the past 12 months?
Krishna Institute of Medical Sciences Limited lowest stock price was ₹575.55 and its highest was ₹798.00 in the past 12 months.
What is Krishna Institute of Medical Sciences Limited’s market cap?
Krishna Institute of Medical Sciences Limited’s market cap is ₹260.93B.
When is Krishna Institute of Medical Sciences Limited’s upcoming earnings report date?
Krishna Institute of Medical Sciences Limited’s upcoming earnings report date is May 14, 2026 which is in 15 days.
How were Krishna Institute of Medical Sciences Limited’s earnings last quarter?
Krishna Institute of Medical Sciences Limited released its earnings results on Feb 06, 2026. The company reported ₹1.3 earnings per share for the quarter, missing the consensus estimate of ₹1.317 by -₹0.017.
Is Krishna Institute of Medical Sciences Limited overvalued?
According to Wall Street analysts Krishna Institute of Medical Sciences Limited’s price is currently Undervalued.
Does Krishna Institute of Medical Sciences Limited pay dividends?
Krishna Institute of Medical Sciences Limited does not currently pay dividends.
What is Krishna Institute of Medical Sciences Limited’s EPS estimate?
Krishna Institute of Medical Sciences Limited’s EPS estimate is 1.53.
How many shares outstanding does Krishna Institute of Medical Sciences Limited have?
Krishna Institute of Medical Sciences Limited has 400,138,950 shares outstanding.
What happened to Krishna Institute of Medical Sciences Limited’s price movement after its last earnings report?
Krishna Institute of Medical Sciences Limited reported an EPS of ₹1.3 in its last earnings report, missing expectations of ₹1.317. Following the earnings report the stock price went down -1.993%.
Which hedge fund is a major shareholder of Krishna Institute of Medical Sciences Limited?
Currently, no hedge funds are holding shares in IN:KIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It also focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, alzheimers, bone, joint center specialties, and others. The company was incorporated in 1973 and is based in Secunderabad, India.
KIMS Stock 12 Month Forecast
Average Price Target
₹792.50
▲(21.36% Upside)
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―